Clinical Trial Update: Role of Microglial Activation and Norepinephrine Transporter Abnormalities in Pathogenesis of MS-related Fatigue [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial investigating microglial activation and norepinephrine transporter abnormalities as factors in multiple sclerosis-related fatigue across Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Multiple Sclerosis | Phase 1, Phase 2 | Status: UNKNOWN